Tag: Multidisciplinary Association for Psychedelic Studies

What Does the FDA Think About Psychedelics?

The investigation of psychedelic drugs for their medical benefits is attracting investors. How does the leading US drug agency feel?

Psychedelic Therapies Emerging as Integrated Health Treatment Options

Psychedelic therapies including psilocybin are increasingly being considered for their remedial and medical benefits by health organizations across North America.

Medical Benefits Fueling Psychedelics Business Boost

INN chatted with Adele Byrne, senior analyst at Prohibition Partners, about the early start for the psychedelics market.